Search results for abx831479

Belantamab, Abbexa, abx831479

Belantamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF17/CD269, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Belantamab mafodotin (GSK2857916) is an antibody-conjugated drug that connects humanized anti-BCMA antibody with a cytotoxic agent. By targeting BCMA, the cytotoxic agent is specifically delivered into MM cells to kill cancer cells. effect.